Lexpos News

/Lexpos News/

LFD service myth busting series (#1)

This is the first of a series of articles to tackle some of the misconceptions around the Lateral Flow Device (LFD) service. The articles will cover a variety of aspects of the LFD service and aims to myth bust, to increase understanding of the service. The LFD service is no longer available from community pharmacies. [...]

The post LFD service myth busting series (#1) appeared first on Community Pharmacy England.

By |October 22nd, 2025|Lexpos News|Comments Off on LFD service myth busting series (#1)

Primary care professions organise joint Parliamentary briefing event

Community Pharmacy England is once again leading the organisation of a joint Parliamentary drop-in event with fellow primary care bodies, continuing a long-running collaborative partnership. Following on from last year’s successful joint event, the 2026 iteration, ‘Future of Primary Care’, will be held in January and is being co-hosted with the British Dental Association, British [...]

The post Primary care professions organise joint Parliamentary briefing event appeared first on Community Pharmacy England.

By |October 21st, 2025|Lexpos News|Comments Off on Primary care professions organise joint Parliamentary briefing event

Medicine Supply Notification: Amiodarone 100mg and 200mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Amiodarone 100mg and 200mg tablets MSN/2025/056 Tier 2 – medium impact Date of issue: 20th May 2025 Amiodarone 100mg and 200mg tablets are in limited supply until w/c 17 November 2025 Amiodarone suspension remains available (Specials). Unlicensed imports of amiodarone 100mg [...]

The post Medicine Supply Notification: Amiodarone 100mg and 200mg tablets appeared first on Community Pharmacy England.

By |October 20th, 2025|Lexpos News|Comments Off on Medicine Supply Notification: Amiodarone 100mg and 200mg tablets

Medicine Supply Notification: Mometasone (Asmanex Twisthaler®) 200micrograms/dose dry powder and 400micrograms/dose dry powder inhalers

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Mometasone (Asmanex Twisthaler®) 200micrograms/dose dry powder and 400micrograms/dose dry powder inhalers MSN/2025/057 Tier 2 – medium impact Date of issue: 20/10/2025 Mometasone (Asmanex Twisthaler®) 200microgram/dose dry powder inhaler (60 dose) is being discontinued from late October 2025. [...]

The post Medicine Supply Notification: Mometasone (Asmanex Twisthaler®) 200micrograms/dose dry powder and 400micrograms/dose dry powder inhalers appeared first on Community Pharmacy England.

By |October 20th, 2025|Lexpos News|Comments Off on Medicine Supply Notification: Mometasone (Asmanex Twisthaler®) 200micrograms/dose dry powder and 400micrograms/dose dry powder inhalers

NHSmail is becoming NHS.net Connect – what pharmacy teams need to know

A new name and look are coming to NHSmail – here’s what it means for pharmacy teams. The NHSmail programme is being rebranded to NHS.net Connect. This change introduces a refreshed look and some new features, but if you use it, your existing NHS.net email address, login details and helpdesk support will stay the same. [...]

The post NHSmail is becoming NHS.net Connect – what pharmacy teams need to know appeared first on Community Pharmacy England.

By |October 20th, 2025|Lexpos News|Comments Off on NHSmail is becoming NHS.net Connect – what pharmacy teams need to know